{"nct_id":"NCT03026166","title":"A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer","status":"TERMINATED","status_verified_date":"2020-07","start_date":"2017-03-30","start_date_type":"ACTUAL","primary_completion_date":"2019-07-03","primary_completion_date_type":"ACTUAL","completion_date":"2019-07-03","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ABBV"]}